EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond the blood–brain barrier: the fate of transcytosed therapeutics

Habib Baghirov

Trends in Pharmacological Sciences · 2025-10 · 46 (10) · 946-957

DOI: 10.1016/j.tips.2025.08.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2025-10. Verfasst von Habib Baghirov. Beteiligte Einrichtung: Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, 20500 Turku, Finland. Electronic address: habib.baghi…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Transcytosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transcytosis across the blood-brain barrier (BBB) enables systemically administered large therapeutics to reach the brain parenchyma, but their fate in the parenchyma ultimately governs their therapeutic effect. Recent studies show that brain parenchymal cell uptake, internalization kinetics, reuptake at the BBB, and diffusion in the brain parenchyma shape the distribution and retention of therapeutics. Target engagement further influences their behavior beyond the BBB. These insights have prompted new strategies to enhance their distribution, retention, and target engagement. These include the selection of transport targets with favorable trafficking properties, the use of anchoring proteins, and modeling-based optimization. This opinion highlights emerging understanding of the fate of therapeutics in the brain parenchyma and outlines strategies to optimize this fate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierTranscytosisHumansAnimalsBrainBiological Transport

Stichwörter der Autor:innen

blood–brain barrierbrain parenchymadistributiondrug deliveryretentiontranscytosis

Autor:innen und Institutionen

  • Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, 20500 Turku, Finland. Electronic address: habib.baghirov@abo.fi.

Förderung

  • European Commission
  • AstraZeneca

Zitieren

APA

Baghirov, H. (2025). Beyond the blood–brain barrier: the fate of transcytosed therapeutics. Trends in Pharmacological Sciences, 46(10), 946-957. https://doi.org/10.1016/j.tips.2025.08.006

Vancouver

Baghirov H. Beyond the blood–brain barrier: the fate of transcytosed therapeutics. Trends in Pharmacological Sciences. 2025;46(10):946-957. doi:10.1016/j.tips.2025.08.006

BibTeX
@article{Baghirov2025,
  author = {Baghirov, Habib},
  title = {Beyond the blood–brain barrier: the fate of transcytosed therapeutics},
  journal = {Trends in Pharmacological Sciences},
  year = {2025},
  volume = {46},
  number = {10},
  pages = {946--957},
  doi = {10.1016/j.tips.2025.08.006}
}
Kostenlos starten →